Results 131 to 140 of about 12,401 (156)

Tenofovir disoproxil fumarate

Reactions Weekly, 2010
  +5 more sources

Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load

Hepatology International, 2021
Dongchun Liu, Zhaozhe Liu, Gu Ye
exaly  

Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection

Pathogens, 2022
Mario Hönemann, Johannes Wiegand, Janett Fischer   +2 more
exaly  

Tenofovir-disoproxil-fumarate

Reactions Weekly, 2020
openaire   +2 more sources

Tenofovir disoproxil fumarate

Reactions Weekly
  +4 more sources

Tenofovir disoproxil fumarate

Reactions Weekly, 2007
openaire   +2 more sources

Environmental Sustainability of the Globalized Pharmaceutical Supply Chains: The Case of Tenofovir Disoproxil Fumarate

ACS Sustainable Chemistry and Engineering, 2023
Yanqiu Tao, Fengqi You
exaly  

Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting

AIDS Patient Care and STDs, 2019
Pia Kivelä, Jussi Sutinen
exaly  

Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B

Gastroenterology, 2014
Petr Husa, Scott Fung, Andrzej Horban
exaly  

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Lancet, The, 2015
Daniel Podzamczer, Paul Edward Sax, Scott Mccallister   +2 more
exaly